¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immune state"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ
  • immune adsorption
    ¸é¿ªÈíÂø
  • immune bacteriolysis
    ¸é¿ª¼¼±Õ¿ëÇØ
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹Î¼º
  • immune conglutinin
    ¸é¿ª±³Âø¼Ò
  • immune cytolysis
    ¸é¿ª¼¼Æ÷¿ëÇØ
  • immune deficiency
    ¸é¿ª°áÇÌ
  • immune deposit
    ¸é¿ªÄ§Âø¹°
  • immune deposit disease
    ¸é¿ªÄ§Âøº´
  • immune deviation
    ¸é¿ª¹ÝÀÀÄ¡¿ìħ
  • immune disorder
    ¸é¿ªÁúȯ, ¸é¿ªÀå¾Ö
  • immune elimination
    ¸é¿ª¿øÁ¦°Å
  • immune globulin
    ¸é¿ª±Û·ÎºÒ¸°
  • immune hemolysis
    ¸é¿ª¿ëÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • secondary immune response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • soluble immune response suppressor
    °¡¿ë¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
  • accessory state
    µ¡»óÅÂ
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • adult ego state
    ¼ºÀÎÀھƻóÅÂ
  • alcoholic paranoid state
    ¾ËÄÚ¿ÃÆíÁý»óÅÂ
  • allergic state
    ¾Ë·¹¸£±â»óÅÂ
  • anxiety state
    ºÒ¾È»óÅÂ
  • anxiety tension state
    ºÒ¾È±äÀå»óÅÂ
  • basal state
    ±âÃÊ»óÅÂ
  • carrier state
    º¸±Õ»óÅÂ
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ
  • central inhibitory state
    ÁßÃß¾ïÁ¦»óÅÂ
  • clouded state
    ȥŹ»óÅÂ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • aids=£¾acquired immune deficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
  • anti-immune body
    Ç׸鿪ü.
  • globulin, immune
    ¸é¿ª±Û·ÎºÒ¸°
  • globulin, immune serum
    ¸é¿ªÇ÷û±Û·ÎºÒ¸°
  • hemagglutination, immune adherence
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • hemolysis, immune
    ¸é¿ª¿ëÇ÷
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • human serum immune globulin
    Àΰ£Ç÷û¸é¿ª±Û·ÎºÒ¸°.
  • immune
    ¸é¿ª(¼º)(Øóæ¹àõ)ÀÇ.
  • immune adherence
    ¸é¿ªºÎÂø(Øóæ¹Üõó·).
  • immune adherence hemagglutination
    ¸é¿ªºÎÂø Ç÷±¸ÀÀÁý
  • immune adherence reaction
    ¸é¿ªºÎÂø¹ÝÀÀ.
  • immune amboceptor =i. body
    ¾ç¼öü(å»áôô÷).
  • immune amnesia syndrome
    ¸é¿ª ±â¾ï»ó½Ç ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • immune cytolysis
    ¸é¿ª¼¼Æ÷¿ëÇØ.
  • immune deficiency disease
    ¸é¿ª°áÇÌÁúȯ<º´>.
  • immune deposit
    ¸é¿ªÄ§Âø¹°.
  • immune deposit disease
    ¸é¿ª(±Û·ÎºÒ¸°)Ä§ÂøÁõÈıº.
  • immune deposit disease
    ¸é¿ª(±Û·ÎºÒ¸°)Ä§ÂøÁõÈıº.
  • immune deviation
    ¸é¿ªÆíÀ§(Øóæ¹ø¶êÈ).
  • immune disorder
    ¸é¿ª Àå¾Ö
  • immune disorders
    ¸é¿ªÀå¾Ö(Øóæ¹î¡äô)
  • immune electron microscopy
    ¸é¿ªÀüÀÚÇö¹Ì°æ¹ý.
  • immune electrophoresis
    ¸é¿ªÀü±â¿µµ¿¹ý.
  • immune elimination
    ¸é¿ªÀ̹°Á¦°Å.
  • immune enhancement
    ¸é¿ªÇÐÀûÃËÁø (Á¾¾çÁõ½ÄÀÇ)
  • immune globulin
    ¸é¿ª±Û·ÎºÒ¸°.
  • immune hemolysis
    ¸é¿ª¿ëÇ÷(¹ÝÀÀ).
  • immune hemolytic anemia
    ¸é¿ª¿ëÇ÷¼º ºóÇ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • steady-state approximation
    Á¤·ù»óÅÂ(ïÒ׺ßÒ÷¾) ¾î¸²¼À
  • steady-state electrolysis
    Á¤·ù»óÅ Àü±âºÐÇØ(ïÒ׺ßÒ÷¾ï³Ñ¨ÝÂú°)
  • steady-state kinetics
    Á¤·ù»óÅ ¿ªÇÐ (ïÒ׺ßÒ÷¾ÕôùÊ)
  • steady-state stacking
    Á¤·ù»óÅÂ(ïÒ׺ßÒ÷¾) Ä¡½×±â
  • transient state isoelectric focusing
    °úµµ»óÅÂ(ΦԤßÒ÷¾) µîÀü(Ôõï³)Æ÷Ä¿½Ì
  • transient state kinetics
    °úµµ»óÅ ¿ªÇÐ(ΦԤßÒ÷¾ÕôùÊ)
  • transition state
    õÀÌ»óÅÂ(ôÃì¹ßÒ÷¾)
  • transition state inhibitor
    õÀÌ»óÅ ÀúÇØÁ¦(ôÃì¹ßÒ÷¾îÁúªð¥)
  • transition state theory
    õÀÌ »óÅ ÀÌ·Ð(ôÃì¹ßÒ÷¾×âÖå)
  • triplet state
    »ïÁßÀÚ »óÅÂ(ß²ñìí­ßÒ÷¾)
  • triploid state
    »ï¹è¼ö »óÅÂ(ß²ÛÃâ¦ßÒ÷¾)
  • two-state model
    ¾ç»ó(å»ßÒ)¸ðµ¨
  • vegetative state
    Áõ½Ä(ñòãÖ) »óÅÂ(ßÒ÷¾)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CMIR cell-mediated immune response
HIB heart infusion broth; hemolytic immune body; Hemophilus influenzae type B [vaccine]
HTIG human tetanus immune globulin
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
Ia immune response gene-associated antigen
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ODMR Optical detection of triplet-state magnetic resonance
PVS Persistent Vegetative State
P.S.E. Present State Examination
POMS Profile Of Mood State
SSF Solid state fermentation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • posthypercapnic state
    ÈÄ °úź»êÁõ »óÅÂ
  • relaxation state
    ÀÌ¿Ï »óÅÂ
  • saturation state
    Æ÷È­ »óÅÂ
  • schizophrenic defective state
    ºÐ¿­Áõ °áÇÔ »óÅÂ
    º´¼¼°¡ Á¤ÁöÇÏ¿© Àΰݿ¡ Áö¼ÓÀûÀÎ °áÇÔÀ» ³²±â´Â °æ¿ì.
  • schizophrenic state
    ºÐ¿­ »óÅÂ, Á¤½Å ºÐ¿­ »óÅÂ
  • solid-state laser
    °íü ·¹ÀÌÀú
    °íü ¹°ÁúÀÌ µµÆ÷µÈ º¸Åë ¹Ì·® ¿ø¼Ò·Î °áÁ¤ ¼ÒÁÖ¸¦ Ȱ¼º ¸ÅÁú·Î »ç¿ëÇÏ´Â ·¹ÀÌÀú. 2±Ø Áø°ø°ü ¶Ç´Â ¹ÝµµÃ¼ ·¹ÀÌÀú´Â º¸Åë °íü ·¹ÀÌÀú¶ó´Â Á¤ÀÇ¿¡ ÀûÇÕÇÏÁö¸¸ ÀÌ ±º¿¡¼­ Á¦¿ÜµÈ´Ù.
  • state
    ±â, ´Ü°è, ÁÖ, Á¶°Ç, »óÅÂ, ºÐ¸®
    Áúº´ ¹ßÀÛÀÇ º¯È­ÇÏ´Â ½ÃÁ¡ ¶Ç´Â ÀüȯÁ¡.
  • state of shock
    Ãæ°Ý »óÅÂ
  • stationary state
    Á¤»ó »óÅÂ, º¯ÇÏÁö ¾ÊÀº »óÅÂ
  • steady state
    Ç×Á¤ »óÅÂ
    µ¿ÀǾî=dynamic equilibrium.
  • steady state free precession
    Ç×Á¤ »óÅ ÀÚÀ¯ ¼¼Â÷
  • twilight state
    ¸ù·Õ »óÅÂ
  • vegetative state
    ½Ä¹° »óÅÂ
  • volume depletion state
    ¿ë·® °í°¥ »óÅÂ, ü¾× °áÇÌ »óÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
twilight state A condition of disordered consciousness during which actions may be performed without the conscious volition of the individual and with no memory of such actions.
Compare: somnambulic epilepsy.
(05 Mar 2000)
excited state <chemistry, radiobiology> An atom or nucleus which possesses more energy than its ground state energy.
(16 Dec 1997)
lacunar state The presence of lacunes in the brain. One of the major factors underlying cerebrovascular disease; high correlation with hypertension and atherosclerosis. Symptomatic forms include pure motor hemiplegia and pure hemisensory syndrome; multiple lacunar infarcts are the most common cause of pseudobulbar palsy.
(05 Mar 2000)
local excitatory state Increased irritability of a nerve fibre or muscle fibre which is produced by an ineffective electrical stimulus; summation of the stimuli may occur, resulting in a propagated impulse if two or more subliminal stimuli are applied in rapid succession.
(05 Mar 2000)
rabies immune globulin Globulin fraction of pooled plasma of high anti-rabies virus titre from immunised persons.
Synonym: rabies immunoglobulin.
(05 Mar 2000)
measles immune globulin A sterile solution of globulin's derived from the blood plasma of normal adult human donors; it is prepared from immune serum globulin that complies with the measles antibody reference standard; a passive immunizing agent.
Synonym: measles immunoglobulin.
(05 Mar 2000)
cellular immune theory A concept, put forth by Elie Metchnikoff, that cells, not antibodies, were responsible for the immune response of an organism.
(05 Mar 2000)
rho(d) immune globulin Immunizing agent containing IgG anti-rho(d) used for preventing rh immunization in rh-negative individuals exposed to rh-positive red blood cells.
(12 Dec 1998)
chickenpox immune globulin Globulin fraction of serum from persons recently recovered from herpes zoster infection; used to prevent infection of high-risk children.
Synonym: chickenpox immunoglobulin.
(05 Mar 2000)
pertussis immune globulin A sterile solution of globulin's derived from the plasma of adult human donors who have been immunised with pertussis vaccine; used both prophylactically and therapeutically.
Synonym: pertussis immunoglobulin.
(05 Mar 2000)
poliomyelitis immune globulin A sterile solution of globulin's that contains those antibodies normally present in adult human blood; it is a passive immunologic agent that attenuates or prevents poliomyelitis, measles, and infectious hepatitis, and confers temporary but significant protection against paralytic polio.
Synonym: poliomyelitis immunoglobulin.
(05 Mar 2000)
primary immune response <immunology> The immune response to the first challenge by a particular antigen. Usually less extensive than the secondary immune response, being slower and shorter lived with smaller amounts of lower affinity antibody being produced.
(18 Nov 1997)
hemic and immune systems The organs involved in the production and functions of the blood and the cellular and molecular components providing defense against foreign organisms or substances.
(12 Dec 1998)
secondary immune response The response of the immune system to the second or subsequent occasion on which it encounters a specific antigen.
(18 Nov 1997)
human measles immune serum Obtained from the blood of a healthy person who has survived an attack of measles.
Synonym: measles convalescent serum.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Mother State
    VirginiaÁÖÀÇ
  • Negro state
    (³²ºÏ ÀüÀï ÀÌÀüÀÇ ³²ºÎÀÇ ³ë¿¹ÁÖ
  • New York State Barge Canal
    ´º¿åÁê ¿îÇϸÁ
  • North Star State
    MinnesotaÁÖÀÇ ¼ÓĪ
  • Nutmeg state
    ¹Ì±¹ ConnecticutÁÖÀÇ ¼ÓĪ
  • Panhandle State
    ¹Ì±¹ ¿þ½ºÆ® ¹öÁö´Ï¾ÆÁÖÀÇ º°Äª
  • Pelican State
    ¹Ì±¹ LouisianaÁÖÀÇ
  • Pine Tree State
    ¹Ì±¹ MainÁÖÀÇ µý À̸§
  • Prairie State
    IllinoisÁÖÀÇ µý À̸§
  • State Department,the
    ±¹¹«¼º
  • State university
    ÁÖ¸³ ´ëÇÐ
  • Sunshine State
    Ç÷θ®´ÙÀÇ ÁÖÀǼÓĪ
  • city-state
    (°í´ë ±×¸®½º µîÀÇ)µµ½Ã ±¹°¡
  • client state
    Á¾¼Ó±¹;ÀÇÁ¸±¹
  • confrontation state
    ÀÎÁ¢ Àû´ë±¹
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á